• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.IL-6R/STAT3/miR-34a 反馈环促进 EMT 介导的结直肠癌侵袭和转移。
J Clin Invest. 2014 Apr;124(4):1853-67. doi: 10.1172/JCI73531. Epub 2014 Mar 18.
2
Soluble IL6R represents a miR-34a target: potential implications for the recently identified IL-6R/STAT3/miR-34a feed-back loop.可溶性白细胞介素6受体是miR-34a的一个靶点:对最近发现的白细胞介素6受体/信号转导和转录激活因子3/miR-34a反馈环的潜在影响。
Oncotarget. 2015 Jun 10;6(16):14026-32. doi: 10.18632/oncotarget.4334.
3
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.结直肠癌中 p53/miR-34a/CSF1R/STAT3 反馈回路的特征。
Cell Mol Gastroenterol Hepatol. 2020;10(2):391-418. doi: 10.1016/j.jcmgh.2020.04.002. Epub 2020 Apr 15.
4
Antagonistic Effects of p53 and HIF1A on microRNA-34a Regulation of PPP1R11 and STAT3 and Hypoxia-induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells.p53 和 HIF1A 对 miR-34a 调控 PPP1R11 和 STAT3 及缺氧诱导的结直肠癌细胞上皮间质转化的拮抗作用。
Gastroenterology. 2017 Aug;153(2):505-520. doi: 10.1053/j.gastro.2017.04.017. Epub 2017 Apr 20.
5
SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.SNAIL 和 miR-34a 的正反馈调节促进了 ZNF281/ZBP99 的上皮-间充质转化。
EMBO J. 2013 Nov 27;32(23):3079-95. doi: 10.1038/emboj.2013.236. Epub 2013 Nov 1.
6
IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells.白细胞介素-6受体/信号转导和转录激活因子3/微小RNA-204反馈环促成上皮性卵巢癌细胞的顺铂耐药性。
Oncotarget. 2017 Jun 13;8(24):39154-39166. doi: 10.18632/oncotarget.16610.
7
CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.CPEB3 通过阻断结直肠癌细胞与肿瘤相关巨噬细胞之间的细胞因子信号转导及转录激活因子 3(IL-6R/STAT3)信号通路来抑制上皮-间质转化。
J Exp Clin Cancer Res. 2020 Jul 11;39(1):132. doi: 10.1186/s13046-020-01637-4.
8
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1.联合敲除 TP53 和 MIR34A 通过增加 IL6R 和 PAI1 的水平促进小鼠结直肠癌的发生和发展。
Gastroenterology. 2018 Dec;155(6):1868-1882. doi: 10.1053/j.gastro.2018.08.011. Epub 2018 Aug 10.
9
Liujunzi decoction exerts potent antitumor activity in oesophageal squamous cell carcinoma by inhibiting miR-34a/STAT3/IL-6R feedback loop, and modifies antitumor immunity.六君子汤通过抑制 miR-34a/STAT3/IL-6R 反馈回路发挥强大的抗肿瘤活性,并调节抗肿瘤免疫。
Phytomedicine. 2023 Mar;111:154672. doi: 10.1016/j.phymed.2023.154672. Epub 2023 Jan 13.
10
Tumor-derived exosomes encapsulating miR-34a promote apoptosis and inhibit migration and tumor progression of colorectal cancer cells under in vitro condition.肿瘤来源的外泌体包裹 miR-34a 在体外条件下促进结直肠癌细胞的凋亡,并抑制其迁移和肿瘤进展。
Daru. 2021 Dec;29(2):267-278. doi: 10.1007/s40199-021-00400-0. Epub 2021 Aug 17.

引用本文的文献

1
Molecular interaction of human papilloma virus (HPV) with microRANs: insights into the development of cervical cancer and treatment approaches.人乳头瘤病毒(HPV)与微小RNA的分子相互作用:对宫颈癌发展及治疗方法的见解
Infect Agent Cancer. 2025 Jul 23;20(1):49. doi: 10.1186/s13027-025-00677-9.
2
Epithelial-mesenchymal transition in colorectal cancer metastasis and progression: molecular mechanisms and therapeutic strategies.上皮-间质转化在结直肠癌转移和进展中的作用:分子机制与治疗策略
Cell Death Discov. 2025 Jul 22;11(1):336. doi: 10.1038/s41420-025-02593-8.
3
The Significance of STAT3 in Colonic Diseases: A Comprehensive Study of Pathological Roles and Therapeutic Implications.STAT3在结肠疾病中的意义:病理作用与治疗意义的综合研究
Cell Biochem Biophys. 2025 Jul 8. doi: 10.1007/s12013-025-01816-0.
4
Recent research advances in interleukin, microRNA and neuroendocrine tumor biomarkers (Review).白细胞介素、微小RNA与神经内分泌肿瘤生物标志物的最新研究进展(综述)
Mol Clin Oncol. 2025 Jun 17;23(2):71. doi: 10.3892/mco.2025.2866. eCollection 2025 Aug.
5
miRTARGET: An integrated web tool for the identification of microRNA targets with potential therapeutic or prognostic value in cancer.miRTARGET:一种用于识别在癌症中具有潜在治疗或预后价值的微小RNA靶点的综合网络工具。
Neoplasia. 2025 Jun 24;67:101202. doi: 10.1016/j.neo.2025.101202.
6
The multifaceted role of microRNAs in colorectal cancer: pathogenesis and therapeutic implications.微小RNA在结直肠癌中的多方面作用:发病机制及治疗意义
Noncoding RNA Res. 2025 May 23;14:65-95. doi: 10.1016/j.ncrna.2025.05.012. eCollection 2025 Oct.
7
Breaking the premetastatic niche barrier: the role of endothelial cells and therapeutic strategies.打破转移前生态位屏障:内皮细胞的作用及治疗策略
Theranostics. 2025 May 25;15(13):6454-6475. doi: 10.7150/thno.113665. eCollection 2025.
8
Inhibition of colorectal carcinogenesis by sunitinib malate: disruption of the IL-6/STAT3/c-MYC/TWIST/MMP2 autocrine signaling axis.苹果酸舒尼替尼对结直肠癌发生的抑制作用:IL-6/STAT3/c-MYC/TWIST/MMP2自分泌信号轴的破坏
Discov Oncol. 2025 May 23;16(1):893. doi: 10.1007/s12672-025-02498-z.
9
Reciprocal Modulation of Tumour and Immune Cell Motility: Uncovering Dynamic Interplays and Therapeutic Approaches.肿瘤与免疫细胞运动的相互调节:揭示动态相互作用及治疗方法
Cancers (Basel). 2025 May 1;17(9):1547. doi: 10.3390/cancers17091547.
10
Exploring miR-301a-3p and osteosarcoma: from expression differences to mechanism of action.探索miR-301a-3p与骨肉瘤:从表达差异到作用机制
Discov Oncol. 2025 May 13;16(1):751. doi: 10.1007/s12672-025-02345-1.

本文引用的文献

1
SNAIL and miR-34a feed-forward regulation of ZNF281/ZBP99 promotes epithelial-mesenchymal transition.SNAIL 和 miR-34a 的正反馈调节促进了 ZNF281/ZBP99 的上皮-间充质转化。
EMBO J. 2013 Nov 27;32(23):3079-95. doi: 10.1038/emboj.2013.236. Epub 2013 Nov 1.
2
Heat shock improves Sca-1+ stem cell survival and directs ischemic cardiomyocytes toward a prosurvival phenotype via exosomal transfer: a critical role for HSF1/miR-34a/HSP70 pathway.热休克通过外泌体转移改善 Sca-1+ 干细胞存活并使缺血性心肌细胞向生存促进表型定向:HSF1/miR-34a/HSP70 通路的关键作用。
Stem Cells. 2014 Feb;32(2):462-72. doi: 10.1002/stem.1571.
3
Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.p53对c-Kit的抑制作用由miR-34介导,且与化疗耐药性降低、迁移能力及干性相关。
Oncotarget. 2013 Sep;4(9):1399-415. doi: 10.18632/oncotarget.1202.
4
Trp53 deficiency protects against acute intestinal inflammation.Trp53 缺失可预防急性肠道炎症。
J Immunol. 2013 Jul 15;191(2):837-47. doi: 10.4049/jimmunol.1201716. Epub 2013 Jun 14.
5
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer.AP4 是结直肠癌细胞上皮间质转化和转移的介体。
J Exp Med. 2013 Jul 1;210(7):1331-50. doi: 10.1084/jem.20120812. Epub 2013 Jun 10.
6
The gastrointestinal tumor microenvironment.胃肠道肿瘤微环境。
Gastroenterology. 2013 Jul;145(1):63-78. doi: 10.1053/j.gastro.2013.03.052. Epub 2013 Apr 10.
7
Regulatory networks defining EMT during cancer initiation and progression.在癌症起始和进展过程中定义 EMT 的调控网络。
Nat Rev Cancer. 2013 Feb;13(2):97-110. doi: 10.1038/nrc3447.
8
Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties.肠肿瘤发生由去分化和获得干细胞样特性引发。
Cell. 2013 Jan 17;152(1-2):25-38. doi: 10.1016/j.cell.2012.12.012. Epub 2012 Dec 27.
9
Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors.肠上皮细胞中 p53 的缺失会产生炎症微环境,从而使致癌物诱导的结直肠肿瘤发生侵袭和淋巴结转移。
Cancer Cell. 2013 Jan 14;23(1):93-106. doi: 10.1016/j.ccr.2012.11.014. Epub 2012 Dec 27.
10
Detection of miR-34a promoter methylation in combination with elevated expression of c-Met and β-catenin predicts distant metastasis of colon cancer.检测 miR-34a 启动子甲基化与 c-Met 和 β-连环蛋白的高表达相结合可预测结肠癌的远处转移。
Clin Cancer Res. 2013 Feb 1;19(3):710-20. doi: 10.1158/1078-0432.CCR-12-1703. Epub 2012 Dec 14.

IL-6R/STAT3/miR-34a 反馈环促进 EMT 介导的结直肠癌侵袭和转移。

IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

出版信息

J Clin Invest. 2014 Apr;124(4):1853-67. doi: 10.1172/JCI73531. Epub 2014 Mar 18.

DOI:10.1172/JCI73531
PMID:24642471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3973098/
Abstract

Members of the miR-34 family are induced by the tumor suppressor p53 and are known to inhibit epithelial-to-mesenchymal transition (EMT) and therefore presumably suppress the early phases of metastasis. Here, we determined that exposure of human colorectal cancer (CRC) cells to the cytokine IL-6 activates the oncogenic STAT3 transcription factor, which directly represses the MIR34A gene via a conserved STAT3-binding site in the first intron. Repression of MIR34A was required for IL-6-induced EMT and invasion. Furthermore, we identified the IL-6 receptor (IL-6R), which mediates IL-6-dependent STAT3 activation, as a conserved, direct miR-34a target. The resulting IL-6R/STAT3/miR-34a feedback loop was present in primary colorectal tumors as well as CRC, breast, and prostate cancer cell lines and associated with a mesenchymal phenotype. An active IL-6R/STAT3/miR-34a loop was necessary for EMT, invasion, and metastasis of CRC cell lines and was associated with nodal and distant metastasis in CRC patient samples. p53 activation in CRC cells interfered with IL-6-induced invasion and migration via miR-34a-dependent downregulation of IL6R expression. In Mir34a-deficient mice, colitis-associated intestinal tumors displayed upregulation of p-STAT3, IL-6R, and SNAIL and progressed to invasive carcinomas, which was not observed in WT animals. Collectively, our data indicate that p53-dependent expression of miR-34a suppresses tumor progression by inhibiting a IL-6R/STAT3/miR-34a feedback loop.

摘要

miR-34 家族成员受抑癌基因 p53 的诱导,已知可抑制上皮间质转化(EMT),因此可能抑制转移的早期阶段。在这里,我们确定人类结直肠癌(CRC)细胞暴露于细胞因子 IL-6 会激活致癌转录因子 STAT3,该因子通过第一内含子中的保守 STAT3 结合位点直接抑制 MIR34A 基因。MIR34A 的抑制对于 IL-6 诱导的 EMT 和侵袭是必需的。此外,我们鉴定了介导 IL-6 依赖性 STAT3 激活的 IL-6 受体(IL-6R)是一个保守的、直接的 miR-34a 靶标。该 IL-6R/STAT3/miR-34a 反馈环存在于原发性结直肠肿瘤以及 CRC、乳腺癌和前列腺癌细胞系中,并与间质表型相关。活跃的 IL-6R/STAT3/miR-34a 循环对于 CRC 细胞系的 EMT、侵袭和转移是必需的,并与 CRC 患者样本中的淋巴结和远处转移相关。CRC 细胞中 p53 的激活通过 miR-34a 依赖的下调 IL6R 表达干扰 IL-6 诱导的侵袭和迁移。在 Mir34a 缺陷小鼠中,结肠炎相关的肠道肿瘤显示出 p-STAT3、IL-6R 和 SNAIL 的上调,并进展为侵袭性癌,而在 WT 动物中则没有观察到。总的来说,我们的数据表明,p53 依赖性表达的 miR-34a 通过抑制 IL-6R/STAT3/miR-34a 反馈环来抑制肿瘤进展。